Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,116.00
Bid: 1,116.00
Ask: 1,118.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.179%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,116.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Jul 2014 07:00

RNS Number : 7799M
CVS Group plc
21 July 2014
 

 

21 July 2014

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2014. Comparative data relates to the year ended 30 June 2013 unless otherwise stated. The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.9%. This figure benefitted from good weather throughout the winter months and is stated after adjusting for one extra day's trading in the year to 30 June 2013. Like-for-like sales performance was strong in all the main businesses, particularly in Animed Direct. CVS continues to see opportunities for organic growth across all of its activities and continues to invest in the estate to capitalise on this potential.

 

Strong organic growth has been achieved in the core veterinary practices especially in the second half of the year. Membership of our Healthy Pet Club loyalty schemes grew by 50,100 (44.8%), from 111,900 pets at the start of the year to 162,000 at the year end. In the previous year membership grew by 46,400. Based on the current run rate these schemes are now contributing over 11% of the total revenue from practices (2013: 9%).

 

The scale and increasing density of our practice network has enabled the Group to open four emergency out-of-hours centres during the year, bringing work previously performed by third parties into the Group. Further opportunities for similar changes will be sought during 2015.

 

Good progress has been made in developing our referrals business with organic growth continuing in the centres that we already operate. In July 2014 we purchased the freehold of Lumbry Park, Alton, Hampshire for £800,000 and we are now developing plans for fitting it out as a first-class multi-disciplinary referral centre. This centre is expected to open in the summer of 2015.

 

It is pleasing to report that significant growth has continued in Animed Direct, our online dispensary. It is currently generating some £10.4 million of annualised revenue, based on revenue for June 2014, compared with £6.7 million based on June 2013. The varying regulatory requirements in Europe have led to a slight delay in launching our planned local language European websites and the first is now expected to be launched within the next few months.

 

Acquisition activity has continued to play an important part in the Group's strategy. In addition to the seven practices acquired in the first half of the year, three practices - 3 Mile (Glasgow), Ashfield (3 sites around Halifax) and Castle (3 sites in Barnard Castle, County Durham) - and a pet crematorium (Silvermere Haven in Cobham) were acquired during the second half. These acquisitions extend the Practice Division's operations and the practices are an excellent geographic fit with the Group's existing surgeries. The acquisition of Silvermere Haven is an important step in the geographic development of our Crematoria Division and will allow almost all of our practices to be serviced internally.

 

All of the acquisitions have been successfully integrated into the Group. The aggregate turnover of acquisitions in their last financial year prior to acquisition totalled £13.3 million. The actual post acquisition turnover of businesses acquired during the year ended 30 June 2014 was £6.6m.

 

The Group now operates a total of 262 veterinary practices across the UK, an on-line dispensary, 5 diagnostic laboratories and 3 pet crematoria.

 

 

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the Group.

 

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell / Alex Wright

Nick Owen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMNDRFGDZM
Date   Source Headline
3rd Dec 20184:41 pmRNSHolding(s) in Company
3rd Dec 201810:30 amRNSGrant of Options under SAYE Option Scheme and TVR
3rd Dec 201810:06 amRNSHolding(s) in Company
30th Nov 20184:53 pmRNSHolding(s) in Company
29th Nov 20181:48 pmRNSResult of AGM
29th Nov 20187:00 amRNSAnnual General Meeting Trading Update
14th Nov 201811:48 amRNSHolding(s) in Company
12th Nov 20183:56 pmRNSHolding(s) in Company
12th Nov 20183:50 pmRNSHolding(s) in Company
6th Nov 20185:11 pmRNSPosting of Annual Report and Notice of AGM
5th Nov 20188:05 amRNSExercise of Options, Directors' Dealing and TVR
31st Oct 20185:32 pmRNSTotal Voting Rights
24th Oct 201810:43 amRNSHolding(s) in Company
16th Oct 201812:51 pmRNSLong Term Incentive Plan Awards
15th Oct 20187:00 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSExercise of Options and Total Voting Rights
27th Sep 20187:00 amRNSPreliminary Results
21st Sep 20184:21 pmRNSHolding(s) in Company
21st Sep 20184:21 pmRNSHolding(s) in Company
24th Aug 201812:22 pmRNSHolding(s) in Company
23rd Aug 20182:56 pmRNSHolding(s) in Company
21st Aug 20184:22 pmRNSHolding(s) in Company
21st Aug 20183:32 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTrading Statement & Board Update
31st Jul 20185:45 pmRNSExercise of Options and Total Voting Rights
20th Jul 20187:00 amRNSBoard Changes and Notice of Trading Update
10th Jul 201810:35 amRNSHolding(s) in Company
6th Jul 20185:11 pmRNSHolding(s) in Company
2nd Jul 20184:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20184:46 pmRNSTotal Voting Rights
2nd Jul 20183:05 pmRNSHolding(s) in Company
19th Jun 20187:00 amRNSBlock listing Interim Review
7th Jun 20184:18 pmRNSHolding(s) in Company
31st May 20183:40 pmRNSExercise of Options and Total Voting Rights
22nd May 20182:47 pmRNSHolding(s) in Company
18th May 20184:33 pmRNSHolding(s) in Company
10th May 20182:33 pmRNSHolding(s) in Company
4th May 20185:31 pmRNSHolding(s) in Company
30th Apr 20184:47 pmRNSTotal Voting Rights
24th Apr 20183:13 pmRNSHolding(s) in Company
23rd Apr 20185:55 pmRNSHolding(s) in Company
10th Apr 20182:26 pmRNSExercise of Options & TVR
4th Apr 201812:05 pmRNSDirector/PDMR and PCA Shareholding
3rd Apr 20188:20 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSTotal Voting Rights
28th Mar 20184:42 pmRNSExercise of Options, Director/PCA Dealing & TVR
20th Mar 20183:06 pmRNSExercise of Options, Directors' dealings and TVR
1st Mar 20183:30 pmRNSTotal Voting Rights
21st Feb 20184:17 pmRNSHolding(s) in Company
16th Feb 20185:36 pmRNSResult of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.